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Abstract
Cardiosphere-derived cells (CDCs), which can be isolated from heart explants, are a promising 
candidate cell source for infarcted myocardium regeneration. However, current protocols used to 
expand CDCs require at least 1 month in vitro to obtain sufficient cells for transplantation. We 
report that CDC culture can be optimized by preconditioning the cells under hypoxia (2% 
oxygen), which may reflect the physiological oxygen level of the stem cell niche. Under hypoxia, 
the CDC proliferation rate increased by 1.4-fold, generating 6 × 106 CDCs with higher expression 
of cardiac stem cell and pluripotency gene markers compared to normoxia. Furthermore, 
telomerase (TERT), cytokines/ligands involved in stem cell trafficking (SDF/CXCR-4), 
erythropoiesis (EPO), and angiogenesis (VEGF) were increased under hypoxia. Hypoxic 
preconditioning was mimicked by treatment with two types of hypoxia-inducible factor (HIF) 
prolyl-4-hydroxylase inhibitors (PHDIs): dimethyloxaloylglycine (DMOG) and 2-(1-chloro-4-
hydroxyisoquinoline-3-carboxamido) acetic acid (BIC). Despite the difference in specificity, both 
PHDIs significantly increased c-Kit expression and activated HIF, EPO, and CXCR-4. 
Furthermore, treatment with PHDIs for 24 h increased cell proliferation. Notably, all hypoxic and 
PHDI-preconditioned CDCs had decreased oxygen consumption and increased glycolytic 
metabolism. In conclusion, cells cultured under hypoxia could have potentially enhanced 
therapeutic potential, which can be mimicked, in part, by PHDIs.
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Introduction
Cardiac stem cells (CSCs) were first identified within the heart in 2002 (25), challenging the 
generally accepted paradigm that the heart is a postmitotic organ (2,61). A relatively low 
number of CSCs can be isolated using specific single cell markers, such as c-Kit (4) or Sca-1 
(49,64). In 2004, Messina et al. developed a method to isolate CSCs from human or murine 
hearts via the formation of cardiospheres (46), which could be further expanded in vitro to 
obtain sufficient cardiosphere-derived cells (CDCs) for transplantation (60). The CDCs were 
clonogenic, expressed stem and endothelial progenitor cell markers, appearing to have the 
properties of adult cardiac stem cells, and resulting in myocardial regeneration and 
functional improvement when injected into the infarcted rodent heart (7,46,60). Johnston et 
al. have shown that administration of fewer than 107 CDCs to the porcine heart resulted in 
minimal long-term engraftment of donor cells (32); however, the culture protocol required at 
least 1 month to obtain sufficient CDCs for therapy, during which time the infarcted heart 
undergoes scar formation and remodeling (19). Furthermore, cells age during multiple in 
vitro passages, triggering variability of stem cell phenotypic and functional characteristics 
(28,33,50,57). Therefore, CDCs would be more beneficial if they could be administered as 
soon as possible after infarction.
It has been shown by us and others that CDC transplantation resulted in significant 
myocardium regeneration and functional benefit for infarcted hearts, both in animal models 
and in clinical trials, yet donor cell retention is low, and complete recovery following CDC 
transplantation has not been fully accomplished (7,27,44). Chimenti et al. demonstrated that 
paracrine mechanisms through the secretion of cytokines played a major role in the overall 
therapeutic potential of CDCs for myocardial infarction (10). Therefore, in this study, we 
aimed to optimize the CDC culture protocol not only to increase the cell proliferation rate 
but also to enhance the cells’ therapeutic potential for myocardial infarction by conditioning 
the cells to a hypoxic environment under hypoxic culture or by stimulating the hypoxic 
response using two prolyl-4-hydroxylase inhibitors (PHDIs): dimethyloxaloylglycine 
(DMOG) and 2-(1-chloro-4-hydroxyisoquinoline-3-carboxamido) acetic acid (BIC) under 
normoxic condition.
Stem cells reside in complex microenvironments, termed niches, the nature of which play 
important roles in determining stem cell division, function, and differentiation (39,54). To 
date, most tissue culture is routinely maintained at atmospheric levels of 21% oxygen, 
whereas the average oxygen concentration of tissue in vivo is about 2–9%, with considerable 
variation based on location (15,53,58). Adult stem cell niches are hypoxic, with oxygen 
levels as low as 1–2%; thus, in vitro cultivation of stem cells in a traditional incubator 
supplied by room air does not recapitulate the in vivo physiological condition and could 
result in a gradual loss of primitive stem cell characteristics (15). Culture under low oxygen 
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concentrations (2–6% O2) enhances cell proliferation rates and reduces apoptosis in human 
and rat mesenchymal stem cells (22,38), neural stem cells (8,62,71), embryonic stem cells 
(30,65), and adipose-derived stem cells (36,52). Here we have isolated cardiac progenitors 
from the atria, which have been shown to be hypoxic (34), and cultured the cells under more 
physiologically relevant oxygen levels (2% O2, termed hypoxia). The resulting changes in 
CDC self-renewal, differentiation, gene expression, and metabolism in vitro were 
investigated and compared with those cultured under atmospheric oxygen (21% O2, termed 
normoxia).
Hypoxia triggers multiple physiological and cellular mechanisms that enable adaptation to 
reduced oxygen availability. Nonetheless, while oxygen concentration plays a major role in 
determining the efficiency of CDC culture, many processes involved in oxygen homeostasis 
also depend on the hypoxia-inducible factor (HIF) transcriptional complex and its inhibitory 
enzyme, prolyl-4-hydroxylase (PHD), which requires 2-oxoglutarate (2OG) as a cosubstrate 
and iron as a cofactor (3,41,66). Our hypothesis was that inhibition of any of these essential 
downregulators of HIF could potently activate the HIF response, mimicking hypoxic 
preconditioning. Therefore, in this study, we also investigated the effect of HIF activation 
using two PHD inhibitors (PHDIs). Our rationale for this study was that stimulating a 
hypoxic response by using PHDIs (pharmaceutical manipulation) may be more practical for 
large-scale culture than physiological manipulation of oxygen levels in vitro. In addition, 
these small cell-permeable inhibitors are specific in reaction, enabling the development of 
targeted inhibition of key downregulators of the HIF transcriptional complex in culture.
In understanding the activation process of the HIF system in the presence of PHDIs, it is 
important to understand the prolyl and asparaginyl hydroxylation pathway of the HIF 
system. The HIF transcriptional complex, which comprises HIF-α and HIF-β subunits, was 
discovered by Semenza and Wang in 1992 (56). HIF-α protein is normally only detectable 
under hypoxic conditions, while HIF-β protein is constitutively stable. Human HIF-α exists 
as three isoforms, of which the two best characterized, HIF-1α and HIF-2α, each contain 
two sites of prolyl hydroxylation and one of asparaginyl hydroxylation (66). Prolyl 
hydroxylation occurs at residues Pro402 and Pro564 of human HIF-1α, as catalyzed by 
PHD isoforms (PHD 1–3), whereas asparaginyl hydroxylation occurs at Asn803 as catalyzed 
by FIH (factor-inhibiting HIF) (3). Both the PHDs and FIH are 2OG-dependent oxygenases, 
and their activity inhibits HIF-mediated transcription, but they act via different mechanisms. 
Prolyl hydroxylation by PHDs marks HIF-1α for degradation by the von Hippel Lindau 
protein (pVHL)–ubiquitin ligase system, which leads to proteasomal degradation of HIF-α 
protein, while asparaginyl hydroxylation by FIH within the HIF-α C-terminal transactivation 
domain (CAD) inhibits the interaction of CAD with CBP/p300 (Creb-binding protein/
protein 300), which are transcriptional coactivators for many HIF target genes, thus reducing 
HIF-mediated expression. Under hypoxia, HIF-α escapes both prolyl and asparaginyl 
hydroxylation, HIF-α translocates to the nucleus and dimerizes with HIF-1β to form 
transcriptionally active heterodimeric HIF (11,42).
Here we report the results of comparing the effects of two inhibitors, which each activated 
HIF via a different pathway: DMOG, a cell-permeable, competitive inhibitor of 2OG 
oxygenases (16), which also inhibits FIH, making it a non-PHD-specific inhibitor; and BIC 
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[also reported as FG2216 (18)], a specific PHD inhibitor, which has been used in clinical 
trials as a proangiogenic compound acting via the HIF-1α system (12). We also compared 
the effects of these inhibitors for HIF stabilization with hypoxic CDC culture and 
investigated whether pharmacological inhibition of PHDs successfully mimicked the effects 
of hypoxic preconditioning.
Materials and Methods
Animals
Sprague–Dawley (SD) female rats were obtained from a commercial breeder (Harlan, Oxon, 
UK). Animals were kept under controlled conditions for temperature, humidity, and light, 
with water and rat chow available ad libitum. Rats were anesthetized with sodium 
pentobarbital (270 mg/kg body weight, IP; Euthatal, Merial, UK) to allow tissue removal. 
Body and heart weights were routinely recorded. All procedures were in accordance with 
Home Office (UK) guidelines under The Animals (Scientific Procedures) Act, 1986, and 
with University of Oxford, UK, institutional guidelines.
Isolation and Expansion of CDCs
Rat CDCs were cultured as previously described (7,60). Briefly, SD rat hearts (4 months 
old) were excised, and heart weights were measured (n = 4). Atrial tissues were minced into 
1-mm2 explant fragments in 0.05% trypsin-EDTA (Invitrogen). A total of 30 explant 
fragments of homogenous size were plated in each Petri dish precoated with fibronectin 
(Sigma-Aldrich). Then 2 ml of complete explant medium (CEM) [Iscove’s modified 
Dulbecco medium, IMDM (Invitrogen) supplemented with 20% fetal bovine serum, FBS 
(Invitrogen)] was added into each dish. The Petri dishes were equally divided between two 
incubators (Wolf Laboratories, UK) adjustable to different O2 concentrations by infusion of 
nitrogen (N2). Normoxic cell culture was set at 21% O2, whereas hypoxic cell culture was 
set at 2% O2, both buffered with 5% CO2. The O2 concentration was monitored 
continuously using an oxygen sensor (Wolf Laboratories). Supporting cells and phase bright 
cells [collectively known as explant-derived cells (EDCs)] grown out from the explants were 
harvested and resuspended in poly-D-lysine-coated 24-well plates with cardiosphere growth 
medium [CGM, 65% Dulbecco’s modified Eagle medium: nutrient mixture F-12 (DMEM/
F12) (Invitrogen), 35% IMDM, 7% FBS added with 2% B27 (Invitrogen), 25 ng/ml 
cardiotrophin (Peprotech), 10 ng/ml human recombinant epidermal growth factor (EGF; 
Promega), 20 ng/ml human recombinant fibroblast growth factor (FGF; Peprotech), and 5 
units/ml thrombin (Sigma-Aldrich)] at a density of 3 × 104 cells per well. Cardiospheres 
were subsequently expanded in CEM on fibronectin-coated tissue culture flasks to generate 
CDCs, which were maintained in culture with CEM changed every 3 days and passaged 
every 5 days until passage 2 (P2). All experiments in this study used P2 CDCs at 70% to 
80% confluency, unless otherwise stated. For measurement of CDC proliferation, cell 
numbers and cell viability for every passage from passage 1 up to passage 5 were quantified 
using a dye-exclusion assay with trypan blue (Sigma-Aldrich) and hematocytometer cell 
counter. To validate this assay, CDCs at passage 4 were seeded at a density of 2,000 cells per 
well in 96-well plates. After 24, 48, 72, and 96 h, cell numbers were quantified using a Live/
Dead® Viability/Cytotoxicity kit (Molecular Probes) according to manufacturer’s 
Tan et al. Page 4
Cell Transplant. Author manuscript; available in PMC 2018 July 12.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
instructions. In this assay, live and dead cells were distinguished by a two-color fluorescence 
with live cells stained with Calcein-AM (green) and dead cells with EthD-1 (red). Two-color 
signals were read using a spectrophotometer at 486 nm and 635 nm, respectively.
Cytotoxicity of PHDIs
This was the first study using PHDI treatment in CDC culture; thus, a careful cytotoxicity 
test across a gradient of PHDI drug concentrations and treatment periods was carried out to 
determine an optimal, sublethal PHDI treatment for CDCs. In-house synthesized DMOG 
powder was weighed and added to CEM to give final concentrations ranging from 0.1 mM 
to 2 mM, based on concentrations used previously (23). In-house synthesized BIC was 
dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich) as previously described (45,66) to 
make stock solution at a concentration of 100 mM. Stock solution was further diluted in 
CEM to give final concentrations ranging from 10 μM to 100 μM based on concentrations 
used previously (29). CDCs were seeded at a density of 2,000 cells per well in 96-well 
plates. From day 1 to day 4, every 24 h, cell numbers were determined by measuring the 
proportion of dead cells using a Live/Dead® Viability/Cytotoxicity kit (Molecular Probes) 
according to manufacturer’s instructions. For subsequent PHDI experiments, CDCs were 
treated with 1 mM DMOG and 30 μM BIC for 24 h under normoxia (21% O2). Proliferation 
of CDCs treated with drugs at these concentrations was measured over 4 days as above.
Cardiomyocyte Differentiation
Cardiomyocyte differentiation was induced using cardiomyocyte differentiation medium 
[CDM; 2% FBS ESQ (embryonic stem cell qualified) (Invitrogen), 1% insulin transferring 
selenium in IMDM: DMEM/F12; 1:1 (Sigma-Aldrich)] supplemented with 1 mM DMSO. 
The DMSO-supplemented CDM was changed every 2 days for 6 days. Cells were washed 
with PBS (Invitrogen) to remove the dead cells, and 2 ml CDM supplemented with 0.1 mM 
ascorbic acid (Sigma-Aldrich) was added to the plate. The medium was changed every 2 
days for the following 6 days (hereafter, the cells treated under such conditions are labeled 
as “DMSO-treated cells” for simplicity). After that, the cells were fixed with 
paraformaldehyde (Sigma-Aldrich) and immunostained with antibodies against α-
sarcomeric actin (1:1,000; Abcam), cardiac troponin T (1:1,000; Abcam), or lysed for 
harvesting of protein and RNA. Negative control cells were treated with CEM for 12 days, 
with the medium changed every 2 days.
Primer Design
Primer pairs were designed using Primer3 software based on interpretation of GenBank or 
Ensembl Genome Browser or were selected from published sequences (47). Primer 
specificity was enhanced by designing a primer pair that flanked the exon–exon border of 
the gene of interest. Primer pairs of specific cardiac stem cell markers (c-Kit), pluripotent 
stem cell markers (Oct-4, Klf-4, Sox 2, and Nanog), cardiac differentiation transcription 
factors (Nkx 2.5 and GATA 4), matured cardiomyocyte markers [troponin T (Tnnt) and 
myosin heavy chain (MyCH)], and mesenchymal stem cell markers (CD90 and CD105) 
were used for CDC characterization, while primer pairs of target gene, such as HIF-1α, 
vascular endothelial growth factor (VEGF), erythropoietin (EPO), telomerase reverse 
transcriptase (TERT), and C-X-C chemokine receptor type 4 (CXCR-4), were used to 
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investigate the effects of hypoxia on CDC culture. The sequences for primers are shown in 
Table 1.
Quantitative (Real-Time) Reverse Transcriptase PCR (qRT-PCR)
Total RNA was extracted from cultured cells using the TRIzol reagent (Sigma-Aldrich) 
according to the manufacturer’s instructions and treated with Turbo DNA-free (Ambion) to 
degrade any DNA present. Complementary DNA (cDNA) was synthesized from the RNA 
template using the AB high-capacity transcriptase kit (Applied Biosystem). Real-time PCR 
amplification was performed using the Applied Biosystems StepOnePlus Real-Time PCR 
System (AB International, CA, USA). After amplification, a melting curve was acquired by 
heating the product at 4°C/s to 95°C, cooling it at 4°C/s to 70°C, keeping it at 70°C for 20 s, 
and then slowly heating it at 4°C/s to 95°C to determine the specificity of PCR products. All 
qRT-PCR data were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and β-actin (Actb) as the reference genes, as previously described (63).
Western Blotting
A total of 50 μg of protein was extracted from normoxic, hypoxic, and PHDI-treated CDCs 
using lysis buffer containing protease inhibitors (Sigma-Aldrich), and subjected to 
immunoblot assay with anti-HIF-1α (1:1,000; Novus), anti-citrate synthase (1:1,000; Alpha 
Diagnostic) and anti-GLUT-1 (1:1,000; Abcam), as previously described (24). Protein 
loading and transfer were confirmed by Ponceau S staining (Sigma-Aldrich), and protein 
levels were normalized to internal standard (rat heart lysates) to ensure homogeneity 
between samples and gels. Bands were quantified using UN-SCAN-IT gel software (Silk 
Scientific), and all samples were run in duplicate on separate gels to confirm results.
Enzyme-Linked Immunosorbent Assay (ELISA) for VEGF
Cell culture medium was collected after the experiment, and the protein concentration of the 
medium was determined using a BCA protein assay kit (Thermo Scientific). A 96-well plate 
was coated with 100 μl/well VEGF capture antibody (R&D System) overnight. An ELISA 
assay was performed according to the manufacturer’s instructions. The secreted VEGF 
protein levels were normalized to total extracellular protein.
Immunocytochemistry
Conditioned CDCs were grown on Nunc Lab-Tek® four-well chamber slides precoated with 
10 μg/ml fibronectin and fixed with 4% paraformaldehyde (Sigma-Aldrich) for 10 min on 
ice. Fixed cells were blocked with 10% donkey serum (Biosera) in 0.1% PBS-Tween [0.9% 
NaCl, 10 mM Tris base, and 0.05% Tween (all Sigma-Aldrich)] for 1 h at room temperature 
and then incubated overnight, at 4°C in a humidified chamber, with the primary antibodies 
anti-cardiac troponin I (cTnI) (1:1,000; Abcam), anti-α-sarcomeric actin (1:1,000; Abcam), 
anti-myosin heavy chain (1:1,000; Abcam), anti-c-Kit (1:1,000; Santa Cruz), anti-CD90 
(1:1,000; BD Pharmingen) anti-Oct-4 (1:1,000; Santa Cruz), anti-Klf-4 (1:1,000; Abcam), 
anti-Nanog (1:1,000; Abcam), or anti-Sox 2 (1:1,000; Santa Cruz) diluted in PBS in the ratio 
1:100. Cells were then incubated with the appropriate secondary antibody conjugated to 
FITC and the immunofluorescence detected using a confocal microscope (Zeiss Confocal 
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LSM 700). For confocal cytometry, the number of positive cells for each protein was 
counted in 10 representative fields.
Measurement of Cell Respiration
Cell oxygen consumption rates were measured using a Clark-type oxygen electrode 
(Strathekelvin Instruments, Scotland) as previously described (48). Two million cells were 
suspended in 500 μl respiratory medium [100 mM KCl, 50 mM MOPS, 1 mM EGTA, 5 mM 
KH2PO4, and 1 mg/ml BSA (all Sigma-Aldrich), pH 7.4] and incubated in a stirred chamber 
at 30°C. Respiration was measured under basal unstimulated conditions for 5 min, followed 
by addition of 10 mM pyruvate and 5 mM malate, 2 mM oligomycin, and 10 mM carbonyl 
cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) (all Sigma-Aldrich). Cell oxygen 
consumption rates in each solution were traced and recorded. Traces were then analyzed 
using Strathekelvin 782 Oxygen System v3.0 software.
Cell Metabolism
Glucose and lactate levels in cell culture medium were determined using an ABX Pentra 400 
Chemistry Analyzer (glucose reagent A11A01668 and lactate reagent A11A01721; Horiba 
Ltd., USA).
Statistical Analysis
Data obtained were expressed as mean ± standard error of the mean (SEM). All statistical 
analyses were performed using Excel, Prism, or SPSS software. The statistical differences of 
measurements made in cells from the same animals were analyzed using a paired t-test, 
whereas multiple comparisons between groups were analyzed using a one-way analysis of 
variance (ANOVA). Repeated-measures ANOVA was performed to compare curves. A 
Tukey post hoc test was used to analyze statistical difference between groups or curves. A 
value of p < 0.05 was considered statistically significant.
Results
Effects of In Vitro Multiple Passaging on CDC
In vitro propagation of cardiac stem cells from EDCs up to passage 10 (P10) CDCs under 
normoxia showed a gradual decrease in expression of mRNA for the telomere reverse 
transcriptase (TERT) enzyme and the cardiac stem cell marker, c-Kit (Fig. 1A, B).
Hypoxia Increased Cell Proliferation Rate
Atrial explants were cultured under normoxia (21% O2) or hypoxia (2% O2). Within 3 to 6 
days in both normoxic and hypoxic cultures, fibroblast-like cells started to migrate away 
from the edge of the explants. Generally, under both normoxia and hypoxia, EDCs became 
confluent and were ready for harvesting within 9 days of plating (Fig. 2A). After 9 days in 
culture under hypoxia, 10.3 ± 0.3 × 105 EDCs were produced from 0.1 g explant tissue, 1.4-
fold more than those generated under normoxia (7.3 ± 1 × 105 EDC/0.1 g). These rates were 
maintained up to day 18, with 22 ± 1 × 105 EDCs/0.1 g generated by hypoxic culture and 18 
± 1 × 105 EDCs/0.1 g generated by normoxic culture (Fig. 2B). EDCs aggregated to form 
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cardiospheres after 2 days in culture. Approximately 400 cardiospheres were obtained from 
each well after 4 days of incubation under normoxia or hypoxia (Fig. 2C), with hypoxic 
cardiospheres forming larger cell clusters (0.033 ± 0.004 mm2) compared with those under 
normoxia (0.017 ± 0.002 mm2) (Fig. 2D). Isolated cardiospheres were replated on 
fibronectin and formed CDCs after 3–4 days of incubation. Hypoxic culture yielded higher 
cell numbers than normoxia at day 5 of each passage from P1 until P5 (Fig. 2E). On average, 
5.2 ± 0.3-fold expansion was observed at each passage for hypoxic cells, whereas normoxic 
CDCs maintained a 3.0 ± 0.1-fold increase during each passage. To further validate the cell 
proliferation data, cell numbers at P4 were quantified using Live/Dead® Viability/
Cytotoxicity assay every 24 h for 4 days. The number of hypoxic cells was significantly 
higher than that of normoxic cells after 48 h, and this increase was maintained up to 96 h in 
culture (Fig. 2F).
Taken together, approximately 6 × 106 P2 CDCs were obtained from hypoxic explants 
within 21 days, a week (or 25%) faster than the same number from normoxic explants.
Hypoxic CDCs Expressed HIF-1α and HIF-1α-Regulated Genes
CDCs cultured under hypoxia expressed significantly higher HIF-1α mRNA (2.9 ± 0.6-
fold), compared with normoxic CDCs (Fig. 3A). In line with this, HIF-1α protein levels 
were 3.7 ± 0.5-fold higher in hypoxic CDCs, compared with normoxic CDCs (Fig. 3A). 
Activation of HIF-1α under hypoxia subsequently upregulated several important genes that 
are known to be HIF regulated, including VEGF (3.5 ± 0.6-fold), EPO (3.3 ± 0.9-fold), 
CXCR-4 (6.7 ± 1.0), and TERT (2.7 ± 0.4-fold) (Fig. 3A). Elevated VEGF protein levels 
were confirmed using ELISA (Fig. 3A).
Hypoxia Increased Cardiac Stem Cell Markers in the CDC Population
Under hypoxia, CDCs showed significantly increased mRNA expression for c-Kit (2.3 
± 0.1-fold) and the pluripotent markers, Oct-4 (2.9 ± 0.5-fold), Klf-4 (3.1 ± 0.6-fold), Sox 2 
(5.4 ± 1.5-fold), and Nanog (4.5 ± 1.1-fold) and with reduced expression of mesenchymal 
markers CD90 and CD105 (32% and 65%, respectively) (Fig. 3A). Changes in mRNA 
expression were reflected in the protein expression levels; we found increased protein 
expression of c-Kit (3.1 ± 0.3-fold) and of the pluripotent markers, Oct-4 (1.5 ± 0.1-fold), 
Klf-4 (2.7 ± 0.5-fold), Nanog (4.1 ± 0.2-fold), and Sox 2 (3.2 ± 0.2-fold), in hypoxic CDCs, 
compared with normoxic CDCs, with a significant decrease in CD90 protein expression by 
56% (Fig. 3A, B). On the other hand, the mRNA expression of cardiac transcription factors, 
Nkx 2.5 and GATA 4, and the mature cardiomyocyte markers Tnnt and MyHC was not 
significantly different after hypoxic culture (Fig. 3A).
Cardiomyocyte Differentiation of Hypoxic CDCs
Under normoxia (21% O2), hypoxic-preconditioned CDCs treated with DMSO showed 
significantly increased Tnnt mRNA expression by 3.0 ± 1.0-fold, compared with nontreated 
hypoxic CDCs (Fig. 4A). However, it was found that the level of Tnnt in DMSO-treated 
hypoxic CDCs was significantly lower than in the DMSO-treated normoxic CDCs (5.2 
± 0.6-fold) (Fig. 4A). These findings indicated that hypoxic-preconditioned cells retained the 
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ability to differentiate into cardiomyocytes; however, this ability was attenuated compared 
with normoxic cells.
In order to investigate the effect of the hypoxic environment on CDC cardiomyogenic 
potential, both normoxic and hypoxic CDCs were differentiated under hypoxia (2% O2). 
Here, the mRNA expression levels of Nkx 2.5 in both normoxic and hypoxic CDCs were not 
significantly increased by treatment with DMSO. Although the expression of Tnnt was 
increased in normoxic CDCs differentiated under hypoxia, the increase was significantly 
lower than that of the same cells differentiated under normoxia (2.1 ± 0.3-fold vs. 5.2 ± 0.6-
fold for hypoxic vs. normoxic environment), indicating that the potential for differentiation 
is partially attenuated under hypoxia (Fig. 4A).
CDCs in culture can differentiate spontaneously, particularly when proliferating slowly, and 
show expression of cardiac proteins including α-sarcomeric actin, myosin heavy chain, and 
troponin T (Fig. 4B, control normoxic, and Fig. 4C, hypoxic CDCs). Differentiation can be 
stimulated further by treatment with DMSO. Immunostaining on CDCs cultured for 2 weeks 
showed higher expression of α-sarcomeric actin, myosin heavy chain, and troponin T in 
those treated with DMSO (Fig. 4B, DMSO-treated normoxic, and Fig. 4C, hypoxic CDCs). 
Moreover, treatment with DMSO induced CDCs to change morphology, compared to 
nontreated CDCs.
Preconditioning Adult CDCs With PHDIs
PHDI cytotoxity was assayed by quantification of the number of dead cells in cultures 
treated with a range of concentration of each drug. At 24 h, both DMOG- and BIC-treated 
cells at all concentrations did not increase the number of dead cells (Fig. 5A, B). Prolonged 
DMOG treatment (4 days) caused cytotoxicity at concentrations above 0.5 mM (Fig. 5A), 
while BIC treatment at all concentrations was not toxic to the cells for up to 4 days (Fig. 
5B).
Protein levels of HIF-1α and the HIF-regulated glucose transporter, GLUT-1, in P2 CDCs 
treated with DMOG and BIC in gradient concentrations also were determined. We found 
that HIF-1α activation by DMOG was time and concentration dependent, being maximal 
after 24 h at 0.5 mM or 1 mM DMOG but not significantly increased at the highest DMOG 
concentration (2 mM) or after prolonged treatment (4 days). Similarly, GLUT-1 expression 
peaked at 24 h after treatment with 1 mM DMOG but decreased after prolonged treatment or 
at higher concentrations of DMOG (Fig. 5Ci). BIC is reported to be a more specific PHDI 
and thus significantly upregulated both HIF-1α and GLUT-1 at low concentrations (30 μM) 
(Fig. 5Cii). Based on the negative cytotoxicity and the optimal HIF-1α and GLUT-1 
expression, treatment with 1 mM DMOG or 30 μM BIC for 24 h was determined as the 
optimum condition for CDC culture and thus was used in the following experiments.
To validate this, cell proliferation and viability assay were assessed on CDCs exposed to 1 
mM DMOG or 30 μM BIC for 24, 48, 72, and 96 h. Both PHDIs increased CDC 
proliferation within the first 24 h, compared with nontreated control cells (p = 0.07 for 
DMOG, p < 0.05 for BIC; Fig. 5D). The toxicity of DMOG over 4 days caused a gradual 
decrease in cell numbers after 24 h, and BIC-treated cells did not proliferate after 24 h, 
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although this may be because they had reached confluence. Thus, after 4 days, the number of 
drug-treated CDCs was not significantly different from that of the control cells (Fig. 5D). 
These data indicated 24-h treatment of 1 mM DMOG and 30 μM BIC were optimal to the 
cells.
Effects of PHDI Preconditioning on CDC Gene Expression
DMOG and BIC treatment increased c-Kit mRNA expression by 1.6 ± 0.2-fold, similarly, 
compared with nontreated normoxic CDCs (Fig. 6A). CD90 mRNA levels were significantly 
reduced after treatment with each PHDI, compared with normoxic cells (Fig. 6A). Unlike 
culture under hypoxia, treatment with PHDIs did not increase mRNA levels of Oct-4, Klf-4, 
Sox 2, and Nanog (data not shown) nor decrease the expression of CD105 (Fig. 6A).
DMOG significantly increased the mRNA levels of EPO, VEGF, and CXCR-4, compared 
with normoxic CDCs, mimicking the hypoxic-preconditioned CDCs. BIC treatment resulted 
in significantly higher EPO levels, compared both with normoxic controls and with DMOG-
treated CDCs, but did not induce upregulation of VEGF mRNA (Fig. 6B).
Effects of PHDI Preconditioning on Cardiomyogenic Differentiation
After induction of cardiomyogenic differentiation of PHDI-treated cells using DMSO, 
increased mRNA expression of Tnnt (DMOG = 1.6 ± 0.1-fold; BIC = 1.7 ± 0.1-fold) 
indicated that PHDI-treated CDCs retained the cardiomyogenic differentiation potential 
(Fig. 7A). However, the mRNA expression of these cardiomyocyte markers in differentiated 
PHDI-treated CDCs was significantly lower compared to differentiated normoxic controls 
(Nkx 2.5 = 6.0 ± 0.7-fold vs. 1.8 ± 0.2-fold vs. 1.5 ± 0.1-fold; Tnnt = 5.2 ± 0.6-fold vs. 1.6 
± 0.1-fold vs. 1.7 ± 0.1-fold for normoxic CDCs vs. DMOG vs. BIC, respectively) (Fig. 7A). 
This indicated that PHDI treatment did not elevate the cardiomyogenic potential of CDCs 
compared to normoxic CDCs, mimicking the effects of hypoxic preconditioning on CDC 
cardiomyogenic potential (see Fig. 4A). The mRNA expression data were confirmed using 
confocal immunostaining (Fig. 7B). Protein expression of sarcomeric actin and Troponin T 
were significantly increased in both DMOG- and BIC-treated CDCs after induction with 
DMSO, mimicking the effects of DMSO on normoxic CDCs (control).
Metabolic Adaptation of Hypoxic or PHDI-Preconditioned CDCs
Reduced Oxygen Uptake—Cellular basal respiration rates were significantly reduced by 
~75% under hypoxia and by ~55% and ~50% after treatment with DMOG or BIC for 24 h, 
respectively (Fig. 8A). Respiration was then maximally stimulated by adding FCCP, an 
uncoupling agent that dissipates the proton gradient across the mitochondrial inner 
membrane (55). Although respiration rates increased in all cells after the addition of FCCP, 
those of hypoxic and PHDI-preconditioned cells remained significantly lower than those of 
normoxic cells, indicating that oxidative respiration was reduced by hypoxic culture or by 
pharmacological activation of HIF.
Citrate synthase protein expression was unchanged in hypoxic and PHDI-preconditioned 
CDCs, confirming that the reduced oxygen consumption did not result from reduced 
mitochrondrial density following hypoxic or PHDI preconditioning (Fig. 8B).
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Increased Glucose Metabolism—The expression of GLUT-1 protein increased 7 ± 2-
fold under hypoxia, compared with normoxia (Fig. 8C). Hypoxic CDCs utilized 0.7 ± 0.1 
mM glucose per million cells per day, 3.3-fold more than normoxic CDCs and produced 1.6 
± 0.1 mM lactate per million cells per day, 2.8-fold more than those produced under 
normoxia (Fig. 8D). After PHDI treatment, a significant increase was found in glucose 
uptake (DMOG = 2.1-fold; BIC = 1.9-fold) and lactate production (DMOG = 2.1-fold; BIC 
= 1.4-fold), compared with normoxic nontreated CDCs (Fig. 8D).
These data suggest that under hypoxia, CDCs adapted to low oxygen conditions by reducing 
oxygen consumption, increasing the expression of GLUT-1 and switching to glycolytic 
metabolism, indicated by the increased glucose consumption and lactate production. This 
adaptation could also be induced by pharmacological inhibition of prolyl hydroxylase 
activity.
Discussion
Hypoxic Preconditioning of CDCs Enhances Their Therapeutic Potential
Stem cells reside in niches where they maintain pluripotency and the potential for self-
replication. However, during each round of DNA replication, processes that underlie 
replicative aging could ultimately lead to the senescence of stem cells due to the telomere 
shortening (43,69). We found that mRNA expression of TERT deteriorated during long-term 
cell passaging, implying cellular aging in vitro. TERT is a reverse transcriptase that 
synthesizes telomere repeats on the telomere ends at the tips of chromosomes, protecting the 
chromosomes from deterioration and also maintaining the overall genomic stability (5,70). 
In various types of stem cells, telomerases function to ensure long-term self-renewal 
capacity via maintenance of telomere length (1,13). Also, it was found that in vitro cell 
propagation gradually decreased the expression of c-Kit. Recent studies have reported a 
similar reduction of c-Kit expression, in purified c-Kit cells and in CDCs over time in 
culture (35). Koninckx et al. demonstrated that clonogenic-derived c-Kit+ cells and CDCs 
lost c-Kit expression after several passages in culture (35), while Gambini et al. showed that 
c-Kit expression was significantly downregulated at the RNA level after four passages (21). 
Thus, in order to optimize the therapeutic potential of adult CDCs, here cells were 
preconditioned with low oxygen or with the hypoxic mimetics: DMOG and BIC.
Enhanced cell proliferation rates were found for EDCs and CDCs under hypoxia, compared 
with under normoxia. Also, hypoxic EDCs formed larger cardiospheres, compared with 
normoxic EDCs, which most likely resulted from rapid proliferation of cardiac stem cells in 
the core of the sphere as suggested by Li et al. (40). Hypoxic preconditioning also 
successfully increased the expression of c-Kit. The CDC population in culture contained 
only a minority of c-Kit+ cells, as has been shown by others (35), but nevertheless CDCs 
have been shown to have beneficial effect in the clinic (44). Despite the current controversy 
as to whether endogenous c-Kit cells are involved in cardiac repair, or their contribution to 
cardiac regeneration is minimal (67), cardiac cells expressing c-Kit have been shown to be 
clonogenic and to be capable of differentiating into beating cardiomyocytes (59), sufficient 
for cardiac regeneration and repair (17), and therefore the expression of c-Kit in populations 
of progenitor cells remains of interest. Additionally, hypoxic preconditioned CDCs showed 
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reduced mesenchymal markers, CD90 and CD105. Cheng et al. reported that CD90 
expression negatively correlates with the therapeutic benefits of CDCs in human (9); 
therefore, we postulate that hypoxic preconditioned CDCs with lower CD90+ cell sub-
population may promote overall benefit of CDC therapy. Proliferating hypoxic cells also 
maintained expression of pluripotent factors Oct-4, Klf-4, Sox 2, and Nanog, with decreased 
expression of mature cardiac genes, in agreement with others (14,18,31). Furthermore, we 
found that the TERT mRNA level was upregulated under hypoxia. Maintenance of CDCs in 
the pluripotent state before in vivo transplantation is important to prevent the cells from 
losing their proliferation ability, karyotype stability, and developmental potential.
In addition, we found that hypoxia attenuated cardiomyogenic differentiation in vitro, 
compared to the normoxic cells. Although the expression of cardiomyocyte genes was 
attenuated under hypoxia, which would affect their differentiation potential into new 
cardiomyocytes in vivo, this attenuation was partial, as we found significantly increased 
expression of Nkx 2.5 and Tnnt (cardiomyocyte genes) in hypoxic-preconditioned CDCs 
treated with DMSO, compared with hypoxic CDCs without DMSO treatment, indicating 
that hypoxic-preconditioned CDCs were still able to differentiate into cardiomyocytes, 
however, at a slower rate. Low oxygen levels are detrimental to the survival of mature 
cardiomyocytes, due in part to increased acidosis and the release of reactive oxygen species 
(6), and thus protective mechanisms may inhibit progenitor cell differentiation. More work is 
required to fully investigate this inhibition, as therapeutically the progenitor cells will be 
administered to the hypoxic environment of the infarct scar.
Hypoxic-preconditioned CDCs showed increased expression of CXCR-4, indicating that 
preconditioning may stimulate cardiac stem cell homing to SDF-1α overexpressed in the 
infarcted heart (68). Under hypoxia, CDCs showed a significant increase in the expression of 
EPO and VEGF, suggesting that hypoxic pretreatment would improve the cardiosphere’s 
ability to trigger new blood vessel regeneration and restore vascular networks (26,51). 
Notably, hypoxic CDCs had approximately 75% lower oxygen consumption and were able 
to switch to a more glycolytic metabolism, suggesting that they may be better adapted to 
survive within the hypoxic infarct scar, compared with normoxic CDCs. Implantation of the 
hypoxic CDCs into the infarcted mouse heart results in greater cell engraftment and better 
functional recovery than treatment with conventionally cultured (normoxic) CDCs (40).
PHDI-Preconditioning Partly Mimicked the Effects of Hypoxic Preconditioning
Our study is the first to use PHDIs to stabilize HIF in CDC culture and so mimic the effects 
of hypoxic CDC culture. Simulation of the hypoxic response using PHDIs could remove the 
necessity for culture in hypoxic incubators, prior to in vivo application of stem cells, 
provided the beneficial effects of hypoxic culture could be replicated pharmacologically. 
One of the advantages of stimulating a hypoxic response by using PHDIs was that 
manipulation using a pharmaceutical maybe more practical and specific to scale up rather 
than physiological manipulation of oxygen levels. Besides that, HIF-1α has a biological 
half-life of only ≈5 min under normoxic conditions (37). Its rapid proteosomal degradation 
upon exposure to ambient air (consisting of 21% oxygen) infers challenges during hypoxic 
Tan et al. Page 12
Cell Transplant. Author manuscript; available in PMC 2018 July 12.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
cell culture maintenance. Intermittent hypoxic/normoxic condition might profoundly affect 
the stabilization of HIF-1α in culture and introduce variability in the end product.
However, pharmacological drugs might induce cytotoxicity beyond threshold concentration; 
thus, a careful cytotoxicity test was performed in this study. The optimal treatment doses for 
the PHDIs with the CDCs, with respect to their optimum potential to activate HIF-1α 
expression and negative cell apoptosis effects (cell numbers were not affected by PHDI 
treatment at these concentrations), were found to be 1 mM DMOG or 30 μM BIC for 24 h. 
Furthermore, we selected these concentrations (1 mM DMOG or 30 μM BIC) because these 
doses significantly stabilized and activated HIF, and therefore induced metabolic changes 
and upregulation of important cytokines including CXCR-4 and EPO. In addition, both 
PHDIs significantly reduced the cardiac mesenchymal cell marker CD90, induced the 
expression of GLUT-1 protein, and glucose uptake and lactate production, and decreased 
cellular oxygen respiration, indicating that PHDI-preconditioned CDCs had adapted to the 
PHDI-induced “hypoxic” condition by reducing oxygen consumption and increasing 
glycolytic metabolism.
However, physiologically induced hypoxia and pharmacologically induced hypoxia resulted 
in different effects on CDCs. For example, hypoxic preconditioning increased the 
proliferation rate of adult CDCs above that of cells cultured under normoxia over 96 h, but 
this effect was not observed in PHDI-preconditioned cells after the initial 24 h. Cells 
cultured under hypoxia continued to proliferate beyond confluence, forming sheets that were 
several cells in thickness, and this was not seen with the PHDI-treated CDCs. Furthermore, 
while DMOG-treated CDCs had significantly increased c-Kit, EPO, and VEGF mRNA 
expression, BIC treatment did not increase VEGF mRNA expression. The different 
responses of CDCs to hypoxic or PHDI preconditioning could be due to variations in the 
ability of hypoxia or the PHDIs to activate the HIF system. Tian et al. (66) reported that 
exposure of cells to different levels of hypoxia showed markedly different effects on each 
site of hydroxylation. They found that while culture under 1% oxygen almost completely 
suppressed prolyl hydroxylation (Pro402 and Pro564) only 40% of asparaginyl (Asn803) 
hydroxylation was suppressed under this condition. The asparaginyl (Asn803) hydroxylation 
that persisted at 1% oxygen was only suppressed at a lower oxygen level (0.2%).
Analysis of two different types of PHDIs also permitted comparison of the differential 
sensitivity of these inhibitors toward HIF hydroxylation. Both of the compounds used in this 
study, DMOG and BIC, are effective inhibitors of HIF hydroxylases. However, they act by 
different mechanisms. DMOG is a generic 2OG analog, which can inhibit other members of 
the superfamily of 2OG-dependent dioxygenases, which is a diverse family with important 
functions, including DNA repair and matrix metabolism. Importantly, in an expression 
analysis of the effect of DMOG in cultured cells (66), DMOG was more effective at 
suppressing HIF asparaginyl hydroxylation compared to HIF prolyl hydroxylation. In 
contrast, BIC specifically inhibited prolyl hydroxylation but did not affect asparaginyl 
hydroxylation, resulting in an incomplete HIF activation. This is in agreement with our data, 
which showed that BIC-treated CDCs had a significantly lower HIF-1α level, compared 
with hypoxic CDCs and DMOG-treated CDCs, resulting in different effects on CDC 
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genotypic and phenotypic levels observed between the hypoxic preconditioning and PHDI-
preconditioning cells.
Conclusion
Hypoxic treatment significantly increased CDC proliferation, shortening the time required to 
obtain adequate cell numbers for therapy, while both hypoxic and PHDI preconditioning 
enhanced the therapeutic potential of CDCs by increasing the expression of CXCR-4, EPO, 
and VEGF. Hypoxic and PHDI-preconditioned CDCs had reduced oxygen consumption 
rates, suggesting that treated cells could survive better after transplantation into the hypoxic 
infarcted myocardium.
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Figure 1. 
In vitro propagation of cardiac stem cells from EDCs up to passage 10 (P10) CDCs showed 
a gradual decrease in (A) TERT and (B) c-Kit mRNA expression levels. mRNA expression 
of all cell types were normalized to the geometric mean of GADPH and Actb (housekeeping 
genes) and EDC (calibrator) (n = 3) (*p < 0.05 vs. EDC; #p < 0.05 between the two groups 
indicated).
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Figure 2. 
Effects of hypoxic preconditioning on EDC proliferation rate, cardiosphere size, CDC 
proliferation rate. (A) Atrial heart tissue (n = 4) was separated into two equal portions and 
cultured under normoxia or hypoxia for up to 18 days. At day 0, the black clump shown at 
the corner (indicated by dashed arrows) was an edge of a freshly plated cardiac tissue 
explant. At day 6, fibroblast-like cells (indicated by dotted arrows) were found migrating 
away from the edge of the explants. At day 9, phase bright cells (indicated by solid arrows) 
were found to grow on top of this fibroblast-like monolayer. All these cells were collectively 
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termed as explant-derived cells (EDCs). (B) EDCs generated under normoxia or hypoxia 
were harvested, and cell numbers were counted. At day 9, hypoxic explants generated 
approximately 1.4-fold more EDCs, compared with normoxic explants, and this rate was 
maintained up to 18 days. (C) Morphology of normoxic and hypoxic cardiospheres (Csp) 
were significantly different, with (D) hypoxic Csp 1.9-fold larger than the normoxic Csp. (E) 
Hypoxia also yielded higher cardiosphere-derived cell (CDC) numbers than normoxia at day 
5 of each passage from P1 until P5 (*p < 0.05 vs. normoxia). (F) CDC proliferation assay 
was validated using Live/Dead® Viability/Cytotoxicity kit (Molecular Probes). Hypoxic 
CDCs at P4 showed higher proliferation than normoxic P4 CDCs after 2 days in culture (*p 
< 0.05 vs. normoxia).
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Figure 3. 
Effects of hypoxic preconditioning on CDC mRNA and protein expression levels. (A) The 
relative mRNA or protein expression of HIF-1α, VEGF, EPO, CXCR-4, TERT, CD105, c-
Kit, CD90, Oct-4, Klf-4, Sox 2, Nanog, Nkx 2.5, GATA 4, Troponin T (Tnnt), and myosin 
heavy chain (MyHC) for normoxic P2 CDCs (represented by black boxes) and hypoxic P2 
CDCs (represented by white boxes) (n = 3). (B) Representative confocal images (of three 
independent experiments) of the immunostaining for c-Kit, CD90, Oct-4, Klf-4, Sox 2, and 
Nanog for normoxic P2 CDCs and hypoxic P2 CDCs. *p < 0.01 versus normoxic P2 CDCs. 
Green fluorescence indicates the specific antibody while blue fluorescence indicates DAPI 
staining. The white boxes indicated the zoomed in area. Scale bars: 50 µm.
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Figure 4. 
Cardiomyocyte differentiation of normoxic and hypoxic P2 CDCs. (A) The relative mRNA 
expression of Nkx 2.5, Tnnt, and MyHC for normoxic and hypoxic P2 CDCs after treatment 
with DMSO for 2 weeks under (i) normoxia (left panel) or (ii) hypoxia (right panel) 
conditions (n = 3). mRNA expression of hypoxic cells was normalized to the geometric 
mean of GAPDH and Actb (housekeeping genes) and nontreated control cells (calibrator). 
*p < 0.05 versus nontreated control. #p < 0.05 between the two groups linked with arrow. 
(B, C) Representative confocal images (of three independent experiments) of the DMSO 
differentiation protocol in normoxia (B) and hypoxia (C). An equal number of cells (8 × 105 
per chamber) of each condition were trypsinized and seeded on four-well chamber slides 
coated with fibronectin (10 µg/ml) and stained with DAPI and α-sarcomeric actin, troponin 
T, or myosin heavy chain. Left panel: normoxic CDCs (control or treated with DMSO), right 
panel: hypoxic CDCs (control or treated with DMSO). Scale bars: 50 µm.
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Figure 5. 
Preconditioning adult CDCs with PHDIs. P2 CDCs at 70% to 80% confluency were treated 
with (A) DMOG and (B) BIC at varying concentrations (n = 4). The percentage of dead cells 
was determined after 24 h and 4 days of treatment. *p < 0.05 versus nontreated control. (C) 
Western blot analysis of HIF-1α (left panel) and GLUT-1 (right panel) protein levels in 70% 
to 80% confluent P2 CDCs treated with (i) DMOG and (ii) BIC with a range of 
concentrations for 24 h or 4 days (n = 3). Protein levels were expressed in arbitrary units 
relative to cells treated with control at 24 h. *p < 0.05 versus control at 24 h; #p < 0.05 
versus corresponding concentration at 24 h; $p < 0.05 between the two groups linked with 
arrow. (D) PHDI-treated CDC proliferation over 4 days of treatment with 1 mM DMOG and 
30 µM BIC (n = 4). Both PHDIs increased cell proliferation for the initial 24 h (p = 0.07 for 
DMOG, p < 0.05 for BIC nontreated control).
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Figure 6. 
Effects of PHDI preconditioning on CDC mRNA expression. Relative mRNA expression of 
c-Kit, CD90, CD105, EPO, VEGF, and CXCR-4 in nontreated P2 CDCs (control) and CDCs 
treated with 1 mM DMOG and 30 µM BIC for 24 h (n = 4), normalized to the geometric 
mean of GAPDH and Actb (housekeeping genes) and nontreated control cells (calibrator). 
*p < 0.05 versus control. #p < 0.05 between two groups indicated.
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Figure 7. 
Effects of PHDI preconditioning on CDC cardiomyogenic differentiation. (A) The relative 
mRNA expression of Nkx 2.5, Tnnt, and MyHC for normoxic and PHDI-treated hypoxic P2 
CDCs after treatment with DMSO for 2 weeks under normoxia (n = 3). mRNA expression of 
PHDI-treated hypoxic cells was normalized to the geometric mean of GAPDH and Actb 
(housekeeping genes) and nontreated control cells (calibrator). *p < 0.05 versus nontreated 
control. (B) Representative confocal images (of three independent experiments) of CDCs 
treated with DMSO or BIC for 24 h, followed by differentiation with DMSO for 2 weeks. 
An equal number of cells (8 × 105 per chamber) of each condition were trypsinized and 
seeded on four-well chamber slides coated with fibronectin (10 µg/ml) and stained with 
DAPI and α-sarcomeric actin or troponin T. Scale bars: 20 µm. All experiments in this study 
used P2 CDCs at 70% to 80% confluency, unless otherwise stated. Scale bars: 20 µm.
Tan et al. Page 26
Cell Transplant. Author manuscript; available in PMC 2018 July 12.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 8. 
Metabolic adaptation of normoxic CDCs, hypoxic CDCs, and CDCs treated with 1 mM 
DMOG and 30 µM BIC for 24 h. (A) Basal and FCCP-uncoupled respiration rates were 
reduced despite unchanged mitochondrial numbers indicated by (B) unchanged citrate 
synthase protein levels. (C) GLUT-1 protein expression, (D) levels of glucose uptake and 
production of lactate were increased, suggesting that hypoxic and PHDI-preconditioned cells 
Tan et al. Page 27
Cell Transplant. Author manuscript; available in PMC 2018 July 12.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
switched to more glycolytic metabolism (n = 3). *p < 0.05 vs. control. All experiments in 
this study used P2 CDCs at 70% to 80% confluency, unless otherwise stated.
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Table 1
List of Primer Sequences
No. Primer Forward Primer 5′ to 3′ Reverse Primer 3′ to 5′
1 Oct-4 GAGGGATGTGGTTCGAGTGT CCAGAGCAGTGACAGGAACA
2 Sox 2 CACAACTCGGAGATCAGCAA CTCCGGGAAGCGTGTACTTA
3 Klf-4 CCACAGACCTGGAAAGTGGT GGAAGACGAGGATGAAGCTG
4 Nanog TACCTCAGCCTCCAGCAGAT AGGCCGTTGCTAGTCTTCAA
5 c-Kit AATCCGACAACCAAAGCAAC TGACATCAGAGTTGGACACCA
6 CXCR-4 GCTACCTTGCCATTGTCCAC ACATCGGCGAAGATGATGTC
7 Nkx 2.5 CATTTTATCCGCGAGCCTAC GTCTGTCTCGGCTTTGTCCA
8 GATA 4 CAGTCCTGCACAGCCTACCT CCGCAGTTGACACACTCTCT
9 Tnnt 2 CGTATTCGCAATGAACGAGA CTGTTCTCCTCCTCCTCACG
10 MyHC TATGAGACGGACGCCATACA CTCCAGAGAGGAGCACTTGG
11 CD90 CAGAATCCCACAAGCTCCAA GCCAGGAAGTGTTTTGAACC
12 CD105 GGTACAGTGCATCGACATGG GCTGGCCTAGCTCTATGGTG
13 HIF-1α GGTGGATATGTCTGGGTTGAG TTCAACTGGTTTGAGGACAGA
14 EPO CCAGCCACCAGAGAGTCTTC TGTGAGTGTTCGGAGTGGAG
15 VEGF-α AATGATGAAGCCCTGGAGTG ATGCTGCAGGAAGCTCATCT
16 TERT AGTGGTGAACTTCCCTGTGG CAACCGCAAGACTGACAAGA
17 GAPDH GGGTGTGAACCACGAGAAAT ACTGTGGTCATGAGCCCTTC
18 Actb CTAAGGCCAACCGTGAAAAG AACACAGCCTGGATGGCTAC
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